Jefferies Reiterates Buy on Varian Medical Systems (VAR) Following Announced PerkinElmer Deal
Get Alerts VAR Hot Sheet
Rating Summary:
8 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Join SI Premium – FREE
Jefferies reiterated a Buy rating and $102.00 price target on Varian Medical Systems (NYSE: VAR) following the company's announced plans to acquire PerkinElmer’s Imaging Components business for $276mn in cash. Varex will fund the transaction with cash drawn from its recently announced $600mm credit facility. As a reminder, Varian will retain $200mn of proceeds from the credit facility, leaving Varex with approximately $124mn in remaining cash post the Perkin transaction; however, the overall balance will likely be higher at spin considering internal cash generation.
Analyst Anthony Petrone commented, "Varex announced plans to acquire PerkinElmer’s Imaging Components business for $276mn in cash. The transaction will add to Varex’s portfolio of flat panel X-ray detector plates, expand it into the adjacent verticals, and be immediately accretive by our math. Overall, the deal sets Varex well heading into the spin early next year and will likely be the first of many tuck-ins as it executes a roll-up strategy of smaller players in the space."
For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.
Shares of Varian Medical closed at $90.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson (JNJ) considers deal for Shockwave Medical (SWAV) - WSJ
- Take-Two Interactive Software (TTWO) to Acquire The Gearbox Entertainment Company
- ONE Group Hospitality (STKS) to Acquire Owner of Benihana
Create E-mail Alert Related Categories
Analyst Comments, Mergers and AcquisitionsRelated Entities
Jefferies & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!